Drug reference and clinical information provider Lexi-Comp has reached an agreement to be sold for an unspecified amount to information services firm Wolters Kluwer.
Hudson, Ohio-based Lexi-Comp sells mobile, online and printed content for doctors, pharmacists, hospitals and universities. The 150-employee company was founded in 1978. It may be best known for publishing drug reference handbooks for doctors that provide detailed information on drug uses and interactions.
Netherlands-based Wolters Kluwer said the deal was part of its strategy to increase its point-of-care offerings, according to a statement from the company.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
“Following completion of the acquisition, our combined businesses will be well positioned to provide a robust portfolio of clinical decision support solutions for professional customers across the healthcare continuum,” said Arvind Subramanian, president of Wolters Kluwer Health Clinical Solutions.
Lexi-Comp provides drug information and medical reference content to more than 1,500 hospitals across the globe, according to the statement.
A Lexi-Comp spokeswoman didn’t immediately return a call.